LV10502A - A new strain of antiquity and its use in the production of antibiotics - Google Patents

A new strain of antiquity and its use in the production of antibiotics

Info

Publication number
LV10502A
LV10502A LV930115A LV930115A LV10502A LV 10502 A LV10502 A LV 10502A LV 930115 A LV930115 A LV 930115A LV 930115 A LV930115 A LV 930115A LV 10502 A LV10502 A LV 10502A
Authority
LV
Latvia
Prior art keywords
antiquity
antibiotics
production
new strain
strain
Prior art date
Application number
LV930115A
Other languages
Latvian (lv)
Other versions
LV10502B (en
Inventor
Jagroop S Dahiya
Original Assignee
Novopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002062023A external-priority patent/CA2062023A1/en
Application filed by Novopharm Ltd filed Critical Novopharm Ltd
Publication of LV10502A publication Critical patent/LV10502A/en
Publication of LV10502B publication Critical patent/LV10502B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A20/00Water conservation; Efficient water supply; Efficient water use
    • Y02A20/40Protecting water resources
    • Y02A20/402River restoration

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LVP-93-115A 1992-02-10 1993-02-10 Novel fungal strain and use thereof in preparation of antibiotics LV10502B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83349692A 1992-02-10 1992-02-10
CA002062023A CA2062023A1 (en) 1992-02-10 1992-02-27 Novel fungal strains and use thereof in antibiotic production

Publications (2)

Publication Number Publication Date
LV10502A true LV10502A (en) 1995-02-20
LV10502B LV10502B (en) 1995-08-20

Family

ID=25674996

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-115A LV10502B (en) 1992-02-10 1993-02-10 Novel fungal strain and use thereof in preparation of antibiotics

Country Status (18)

Country Link
EP (1) EP0556699A1 (en)
JP (1) JPH0622780A (en)
CN (1) CN1076965A (en)
AU (1) AU667498B2 (en)
BG (1) BG61180B1 (en)
BR (1) BR9300467A (en)
CZ (1) CZ17293A3 (en)
EE (1) EE03048B1 (en)
FI (1) FI930561A (en)
HR (1) HRP930134A2 (en)
HU (1) HUT67061A (en)
IL (1) IL104481A0 (en)
LV (1) LV10502B (en)
NO (1) NO930446L (en)
NZ (1) NZ245713A (en)
PL (1) PL297691A1 (en)
SI (1) SI9300068A (en)
SK (1) SK5593A3 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849881A (en) * 1989-05-05 1998-12-15 Baylor College Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
IL94183A (en) 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
US5766939A (en) * 1989-05-05 1998-06-16 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
US6100054A (en) * 1989-05-05 2000-08-08 Baylor College Of Medicine Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms
US5571691A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
EP0726940A4 (en) 1993-11-02 2001-05-23 Merck & Co Inc Dna encoding triol polyketide synthase
CN1171400A (en) * 1996-03-05 1998-01-28 武田药品工业株式会社 Xantone compounds, their production and use
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof
PL335227A1 (en) * 1997-02-20 2000-04-10 Dsm Nv Industrial-scale production of valuable compounds by fermentation in a chemically defined medium
IL132822A0 (en) * 1998-03-20 2001-03-19 Biogal Gyogyszergyar Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
US6391583B1 (en) 1998-12-18 2002-05-21 Wisconsin Alumni Research Foundation Method of producing antihypercholesterolemic agents
EP1176208A1 (en) * 2000-07-28 2002-01-30 Société des Produits Nestlé S.A. Koji molds and use thereof for preparing cholesterol-lowering products
EP1357807B1 (en) 2001-02-09 2007-03-14 Unilever N.V. Food product comprising soy protein and statins
KR100423892B1 (en) * 2001-12-03 2004-03-22 씨제이 주식회사 A new process of lactonization in the preparation of statins
WO2006035295A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Process for the purification of lovastatin
CN102533893A (en) * 2010-12-09 2012-07-04 浙江海正药业股份有限公司 Method for preparing monacolin J
CN104277980B (en) * 2013-07-09 2020-04-21 丰益(上海)生物技术研发中心有限公司 Method for separating and purifying aspergillus oryzae transformant
CN105602856B (en) * 2015-12-16 2019-04-16 浙江师范大学 Aspergillus niger (Aspergillus niger) An-19 bacterial strain and its purposes and fermentation process of the production for Lovastatin
CN108118042B (en) * 2016-11-30 2021-01-15 中国科学院青岛生物能源与过程研究所 2-methylbutyrate side chain hydrolase, Monacolin J-producing aspergillus strain, and construction method and application thereof
CN111117894B (en) * 2019-11-26 2023-11-10 漳州大北农农牧科技有限公司 Aspergillus oryzae strain and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus
WO1987003907A1 (en) * 1985-12-17 1987-07-02 Lubrizol Genetics, Inc. Isolation of genes for biosynthesis of polyketide antibiotics
FI104984B (en) * 1988-08-11 2000-05-15 Dsm Nv Method for Identifying and Using Biosynthetic or Regulatory Genes to Improve Secondary Metabolite Production

Also Published As

Publication number Publication date
IL104481A0 (en) 1993-05-13
AU667498B2 (en) 1996-03-28
NO930446D0 (en) 1993-02-09
FI930561A0 (en) 1993-02-09
HUT67061A (en) 1995-01-30
LV10502B (en) 1995-08-20
NO930446L (en) 1993-08-11
CZ17293A3 (en) 1993-12-15
BG97421A (en) 1994-03-24
SI9300068A (en) 1993-09-30
EP0556699A1 (en) 1993-08-25
PL297691A1 (en) 1994-01-24
CN1076965A (en) 1993-10-06
HRP930134A2 (en) 1995-10-31
BR9300467A (en) 1993-08-17
BG61180B1 (en) 1997-02-28
JPH0622780A (en) 1994-02-01
FI930561A (en) 1993-08-11
HU9300330D0 (en) 1993-04-28
AU3212193A (en) 1993-08-12
EE03048B1 (en) 1997-10-15
SK5593A3 (en) 1993-12-08
NZ245713A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
LV10502A (en) A new strain of antiquity and its use in the production of antibiotics
DE69318182D1 (en) METALION REDUCTION IN RAW MATERIALS
ZA9215B (en) Oxides and the production thereof
DE69226183D1 (en) LIQUID-TREATED POLYTETRAFLUROAETHYLENE PRODUCTS AND THEIR PRODUCTION
LTIP328A (en) Novel fungal strains and use thereof in antibiotic production
DK5588D0 (en) PRESSURE REDUCER WITH REGULAR EFFECT PRESSURE
DE69421172D1 (en) SYNTHETISES DETERGENSTUECK AND PRODUCTION THEREOF
AU644297B2 (en) A 1-pyridylimidazole derivative and its production and use
DK601587A (en) PRESSURE REDUCER WITH REGULAR EFFECT PRESSURE
LV12067A (en) Use of 17B-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-one in the manufacture of a medicament
HU9300595D0 (en) New hetero-aryl-oxi-beta-carbolines, their production and application in medicament
SG49830A1 (en) Vaccine design and production
IT9021992V0 (en) PRESSURE REDUCER WITH INCLINED VALVE
AU2759988A (en) Beta-hydroxyketone and its production
GB2252080B (en) Tassels and their production
GB2236526A (en) Lightweight molding and production thereof
AU9021491A (en) Improvements in and relating to the production of helically wound tubing of non-circular cross section
PL276753A2 (en) A subsole and the way of its production
AUPM387594A0 (en) Improvements in and relating to the use of a plurality of G.U.I. applications
TH14095EX (en) chair
GB9116682D0 (en) Particulate materials,their production and use
GB9110154D0 (en) Yeasts and their use in astaxanthin production
ZA9710178B (en) A new physical form of Artemisinin and its use in the production of pharmaceuticals.
ZA947306B (en) Azole compounds their production and use
ZA929146B (en) Optically active azole compounds their production and use